Solazyme, Inc. (NASDAQ: SZYM),
a leading innovator in microalgae food ingredients, announced today that they will be showcasing two ingredients, Whole Algal Protein and Whole Algal Flour, at SupplySide West (SSW) November 14
in Las Vegas. The breakthrough Whole Algal Protein is a vegan, all-natural source of good quality protein that is highly digestible, while the Whole Algal Flour is a multi-functional, lipid rich ingredient that can efficiently replace fat sources or enhance mouth feel in a multitude of different applications, including powder blends, bars and beverages. These microalgae-derived, whole-food ingredients are also naturally rich in fiber and micronutrients. Solazyme will be sampling Whole Algal Protein and Whole Algal Flour applications at Booth 32086.
“We believe Solazyme’s Whole Algal Protein and Whole Algal Flour are game-changing solutions for the nutrition industry because they operate as whole-food ingredients, all while providing natural, clean label benefits,” said Jean-Marc Rotsaert, Chief Operating Officer, Solazyme.
Whole Algal Protein and Whole Algal Flour are products in Solazyme’s suite of microalgae food ingredients, which also includes a revolutionary food oils portfolio.
To learn more about Solazyme’s innovative suite of microalgae ingredients, please visit the sales team at SSW Booth 32086 or visit us at
About Solazyme, Inc.
Solazyme, Inc. (SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils and innovative microalgal food ingredients. Headquartered in South San Francisco, Solazyme’s renewable products can replace or enhance oils derived from the world's three existing sources — petroleum, plants and animal fats.
Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.
Forward Looking Statements
This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about Solazyme, including statements that involve risks and uncertainties concerning: Solazyme’s commercialization plans for microalgae food ingredients and the performance and health benefits of Solazyme’s microalgae food ingredients. When used in this press release, the words “will”, “expects”, “intends” and other similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any such statement may be influenced by a variety of factors, many of which are beyond the control of Solazyme, that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this press release due to a number of risks and uncertainties. Potential risks and uncertainties include, among others: Solazyme’s limited operating history; its limited history in commercializing products; implementation risk in deploying new technologies and products; and market acceptance of its products. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Solazyme. In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q, as updated from time to time, for a discussion of these and other risks. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Solazyme is not under any duty to update any of the information in this press release.